Phospholipase D2 (PLD2) generates phosphatidic acid through hydrolysis of phosphatidylcholine. PLD2 has been shown to play a role in enhancing tumorigenesis. The epidermal growth factor receptor (EGFR) can both activate and interact with PLD2. Murine lymphoma EL4 cells lacking endogenous PLD2 present a unique model to elucidate the role of PLD2 in signal transduction. In the current study, we investigated effects of PLD2 on EGF response. Western blotting and RT-PCR were used to establish that both parental cells and PLD2 transfectants express endogenous EGFR. Levels of EGFR protein are increased in cells expressing active PLD2, as compared to parental cells or cells expressing inactive PLD2. EGF stimulates proliferation of EL4 cells transfected with active PLD2, but not parental cells or cells transfected with inactive PLD2. EGF-mediated proliferation in cells expressing active PLD2 is dependent on the activities of both the EGFR and the PI3K/Akt pathway, as demonstrated by studies using protein kinase inhibitors. EGF-induced invasion through a synthetic extracellular matrix is enhanced in cells expressing active PLD2, as compared to parental cells or cells expressing inactive PLD2. Taken together, the data suggest that PLD2 acts in concert with EGFR to enhance mitogenesis and invasion in lymphoma cells.
References
[1]
Banno, Y. Regulation and possible role of mammalian phospholipase D in cellular functions. J. Biochem.？2002, 131, 301–306, doi:10.1093/oxfordjournals.jbchem.a003103. 11872157
[2]
Foster, D.A.; Xu, L. Phospholipase D in cell proliferation and cancer. Mol. Cancer Res.？2003, 1, 789–800. 14517341
[3]
Meier, K.E.; Gibbs, T.C.; Knoepp, S.M.; Ella, K.M. Expression of phospholipase D isoforms in mammalian cells. Biochem. Biophys. Acta.？1999, 1439, 199–213. 10425396
[4]
McDermott, M.; Wakelam, M.J.; Morris, A.J. Phospholipase D. Biochem. Cell Biol.？2004, 82, 225–253, doi:10.1139/o03-079. 15052340
[5]
Powner, D.J.; Wakelam, M.J. The regulation of phospholipase D by inositol phospholipids and small GTPases. FEBS Lett.？2002, 531, 62–64, doi:10.1016/S0014-5793(02)03410-5. 12401204
[6]
Exton, J.H. Regulation of phospholipase D. FEBS Lett.？2002, 531, 58–61, doi:10.1016/S0014-5793(02)03405-1. 12401203
[7]
Liscovitch, M.; Czarny, M.; Flucci, G.; Lavie, Y.; Tang, X. Localization and possible functions of phospholipase D isozymes. Biochim. Biophys. Acta.？1999, 1439, 245–263, doi:10.1016/S1388-1981(99)00098-0. 10425399
[8]
Ktistakis, N.T.; Delon, C.; Manifava, M.; Wood, E.; Ganley, I.; Sugars, J.M. Phospholipase D1 and potential targets of its hydrolysis product, phosphatidic acid. Biochem. Soc. Trans.？2003, 31, 94–97. 12546662
[9]
O'Luanaigh, N.; Pardo, R.; Fensome, A.; Allen-Baume, V.; Jones, D.; Holt, M.R.; Cockcroft, S. Continual production of phosphatidic acid by phospholipase D is essential for antigen-stimulated membrane ruffling in cultured mast cells. Mol. Biol. Cell.？2002, 13, 3730–3746, doi:10.1091/mbc.E02-04-0213. 12388770
[10]
Lehman, N.; Ledford, B.; Fulvio, M.; Frondorf, K.; McPhail, L.C.; Gomez-Cambronero, J. Phospholipase D2-derived phosphatidic acid binds to and activates ribosomal p70 S6 kinase independently of mTOR. FASEB J.？2007, 21, 1075–1087, doi:10.1096/fj.06-6652com. 17242159
[11]
Jang, I.H.; Lee, S.; Park, J.B.; Kim, J.H.; Lee, C.S.; Hur, E.M.; Kim, I.S.; Kim, K.T.; Yagisawa, H.; Suh, P.G.; Ryu, S.H. The direct interaction of phospholipase C-g1 with phospholipase D2 is important for epidermal growth factor signaling. J. Biol. Chem.？2003, 278, 18184–18190, doi:10.1074/jbc.M208438200. 12646582
[12]
Yang, L.Q.; Seifert, A.; Wu, D.F.; Wang, X.; Rankovic, V.; Schroeder, H.; Brandenberg, L.O.; Hoellt, V.; Koch, T. Role of phospholipase D2/phosphatidic acid signal transduction in μ- and d-opioid receptor endocytosis. Mol. Pharmacol.？2010.
[13]
Luquain, C.; Singh, A.; Wang, L.; Natarajan, V.; Morris, A.J. Role of phospholipase D in agonist-stimulated lysophosphatidic acid synthesis by ovarian cancer cells. J. Lipid Res.？2003, 44, 1963–1975, doi:10.1194/jlr.M300188-JLR200. 12837850
[14]
Lee, J.H.; Kim, Y.M.; Ki, N.W.; Kim, J.W.; Her, E.; Kim, B.K.; Kim, J.H.; Ryu, S.H.; Park, J.W.; Seo, D.W.; Han, J.W.; Beaven, M.A.; Choi, W.S. Phospholipase D2 acts as an essential adaptor protein in the activation of Syk in antigen-stimulated mast cells. Blood？2006, 108, 956–964, doi:10.1182/blood-2005-10-009159. 16861349
[15]
Knoepp, S.M.; Chahal, M.S.; Xie, Y.; Zhang, Z.; Brauner, D.J.; Hallman, M.A.; Robinson, S.A.; Han, S.; Imai, M.; Tomlinson, S.; Meier, K.E. Effects of active and inactive phospholipase D2 on signal transduction, adhesion, migration, invasion, and metastasis in EL4 lymphoma cells. Mol. Pharmacol.？2008, 74, 574–584, doi:10.1124/mol.107.040105. 18523140
[16]
Chen, Y.; Rodrik, V.; Foster, D.A. Alternative phospholipase D/mTOR survival signal in human breast cancer cells. Oncogene？2005, 24, 672–679, doi:10.1038/sj.onc.1208099. 15580312
[17]
Zhao, Y.; Ehara, H.; Akao, Y.; Shamoto, M.; Nakagawa, Y.; Banno, Y.; Deguchi, T.; Ohishi, N.; Yagi, K.; Nozawa, Y. Increased activity and intranuclear expression of phospholipase D2 in human renal cancer. Biochem. Biophys. Res. Commun.？2000, 278, 140–143, doi:10.1006/bbrc.2000.3719. 11185526
[18]
Rodriquez-Gonzalez, A.; Ramirez de Molina, A.; Benitez-Rajal, J.; Lacal, J.C. Phospholipase D and choline kinase: their role in cancer development and their potential as drug targets. Prog. Cell Cycle Res.？2003, 5, 191–201. 14593713
Chen, J.; Fang, Y. A novel pathway regulating the mammalian target of rapamycin (mTOR) signaling. Biochem. Pharmacol.？2002, 64, 1071–1077, doi:10.1016/S0006-2952(02)01263-7. 12234610
[21]
Zhong, M.; Joseph, T.; Jackson, D.; Beychenok, S.; Foster, D.A. Elevated phospholipase D activity induces apoptosis in normal rat fibroblasts. Biochem. Biophys. Res. Commun.？2002, 298, 474–477, doi:10.1016/S0006-291X(02)02495-6. 12408976
[22]
Yamada, Y.; Hamajima, N.; Kato, T.; Iwata, H.; Yamamura, Y.; Shinoda, M.; Suyama, M.; Mitsudomi, T.; Tajima, K.; Kusakabe, S.; Yoshida, H.; Banno, Y.; Akao, Y.; Tanaska, M.; Nozawa, Y. Association of a polymorphism of the phospholipase D2 gene with the prevalence of colorectal cancer. J. Mol. Med.？2003, 81, 126–131. 12601529
Barnes, C.J.; Kumar, R. Biology of the epidermal growth factor receptor family. Cancer Treat. Res.？2004, 119, 1–13. 15164870
[27]
Ciardiello, F.; Tortora, G. EGFR antagonists in cancer treatment. N. Engl. J. Med.？2008, 358, 1160–1174, doi:10.1056/NEJMra0707704. 18337605
[28]
Sundaram, M.; Cook, H.W.; Byers, D.M. The MARCKS family of phospholipid binding proteins: Regulation of phospholipase D and other cellular components. Biochem. Cell Biol.？2004, 82, 191–200, doi:10.1139/o03-087. 15052337
[29]
Kim, S.W.; Hayashi, M.; Lo, J.F.; Yang, Y.; Yoo, J.S.; Lee, J.D. ADP-ribosylation factor 4 small GTPase mediates epidermal growth factor receptor-dependent phospholipase D2 activation. J. Biol. Chem.？2003, 278, 2661–2668, doi:10.1074/jbc.M205819200. 12446727
[30]
Lee, H.Y.; Park, J.B.; Jang, I.H.; Chae, Y.C.; Kim, J.H.; Kim, I.S.; Suh, P.G.; Ryu, S.H. Munc-18-1 inhibits phospholipase D activity by direct interaction in an epidermal growth factor-reversible manner. J. Biol. Chem.？2004, 279, 16339–16348, doi:10.1074/jbc.M310976200. 14744865
Ku, H.; Meier, K.E. Phosphorylation of paxillin via the ERK mitogen-activated protein kinase cascade in EL4 thymoma cells. J. Biol. Chem.？275, 15, 11333–11340.
Van Kolen, K.; Gilany, K.; Moens, L.; Esmans, E.L.; Slegers, H. P2Y12 receptor signaling towards PKB proceeds through IGF-1 receptor cross-talk and activation of Src, Pyk2 and Rap1. Cell Signal.？2008, 18, 1169–1181.
[36]
Bor, M.V.; Sorensen, B.S.; Rammer, P.; Nexo, E. Calibrated user-friendly reverse transcriptase-PCR assay: Quantitation of epidermal growth factor receptor mRNA. Clin. Chem.？1998, 44, 1154–1160. 9625037
[37]
Rehman, A.; Taishi, P.; Fang, J.; Majde, J.A.; Krueger, J.M. The cloning of a rat peptidoglycan recognition protein (PGRP) and its induction in brain by sleep deprivation. Cytokine？2001, 13, 8–17, doi:10.1006/cyto.2000.0800. 11145837
